Legislators
Bills
Statements
Lobbying
Travel
Searching...- Bills
- H.R.5122
H.R.5122: To prohibit further action on the proposed rule regarding testing of Medicare part B prescription drug models.
About This Bill
- This bill was introduced in the 114th Congress
- This bill is primarily about health
- Introduced April 29, 2016
- Latest Major Action May 12, 2016
Bill Sponsor
Bill Cosponsors
22 (2 Democrats, 20 Republicans)
Bill Summary
This bill prohibits the Department of Health and Human Services from taking any further action on a proposed rule to change how Medicare pays for certain drugs that are typically not self-administered (such as some intravenous medications and chemotherapy drugs).
(Source: Library of Congress)
What Lawmakers Are Saying About This Bill
Congressional Budget Office Estimate
Bill Actions
| Date | Description |
|---|---|
| May 12, 2016 |
Referred to the Subcommittee on Health.
|
| May 6, 2016 |
Referred to the Subcommittee on Health.
|
| April 29, 2016 |
Referred to House Ways and Means
|
| April 29, 2016 |
Referred to House Energy and Commerce
|
| April 29, 2016 |
Introduced in the House by Larry Bucshon (R-Ind.) |